Navigation Links
Identification of dopamine 'mother cells' could lead to future Parkinson's treatments
Date:4/7/2008

Mother cells which produce the neurons affected by Parkinsons disease have been identified by scientists, according to new research published in the journal Glia.

The new discovery could pave the way for future treatments for the disease, including the possibility of growing new neurons, and the cells which support them, in the lab. Scientists hope these could then be transplanted into patients to counteract the damage caused by Parkinsons.

The new study focuses on dopaminergic neurons brain cells which produce and use the chemical dopamine to communicate with surrounding neurons. The researchers found that these important neurons are created when a particular type of cell in the embryonic brain divides during the early stages of brain development in the womb.

If a person suffers from Parkinsons disease, it is the depletion of these dopaminergic neurons and the associated lack of dopamine in the body which causes chronic and progressive symptoms including tremors, stiff muscles and slow movement.

The international research team used mouse models in the laboratory to examine the early stages of brain formation. They discovered that dopaminergic neurons are formed by precursor cells identified as radial glia-like cells by the scientists because of their similarity to radial glia cells which are already known to build other parts of the brain.

The scientists hope that this discovery could, in the future, lead to new therapies which would use these radial glia-like cells derived from patients own stem cells to grow replacement neurons in the lab, which could then be transplanted into the brain to replace the neurons they have lost.

One of the authors of the paper, Dr Anita Hall from Imperial College Londons Department of Life Sciences, explains the potential of the teams findings: You could call these radial glia-like cells the stem cells of this part of the brain they contain all the information needed to create and support the young dopamine-producing neurons which are essential for important human functions including motor activity, cognition and some behaviours.

Now that we understand how these neurons are produced, we hope that this knowledge can be used to develop novel therapies including techniques to create replacement neurons for people with Parkinsons which could be implanted into the brain to bolster their vital supplies of dopamine.

Dr Hall adds, however, that more research is needed to work out how exactly these glia-like cells could be used: Using these mother cells to grow new neurons in the lab which are fit to be transplanted into humans will be complicated, and extensive further research is needed before this becomes a clinical reality. For example, were not yet sure whether the mother cells themselves would need to be transplanted too, in order to facilitate successful dopamine production in the brain of a Parkinsons patient, she said.

In the UK, one in every 500 people approximately 120,000 individuals has Parkinsons disease. Around 10,000 people are diagnosed with the disease every year. The symptoms of Parkinsons disease usually appear when about 80% of the brains dopamine has been lost. The level of dopamine in the brain then continues to fall slowly over many years. The reasons why the loss of dopamine occurs in the brains of people with Parkinsons is currently unknown.


'/>"/>

Contact: Danielle Reeves
danielle.reeves@imperial.ac.uk
44-020-759-42198
Imperial College London
Source:Eurekalert

Related medicine news :

1. Community Health Centers Reveal Specific Ramifications of The Medicaid Citizenship and Identification Documentation Requirements
2. Identification of new genes shows a complex path to cell death
3. Forsyth launches 1-of-a-kind core service to enable rapid identification of bacterial samples
4. Isis Announces Approximately $2.8 Million in Government Grants and Contracts Awarded to its Ibis Subsidiary to Advance Ibis Pathogen Identification Technology
5. Body identification by facial reconstruction will cost less time and money
6. Food restriction increases dopamine receptor levels in obese rats
7. Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine
8. FDA Warns of Codeine Risk for Some Nursing Mothers
9. Mother and Daughter Create Lead-Free/Safe Bibs and Solve Messy Mealtime Problems
10. Mothers Know Best: NFL Moms Team With Eddie George to Showcase a Better Way to a Healthier Lifestyle
11. Chemotherapy may be culprit for fatigue in breast cancer survivors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology: